These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8467500)

  • 1. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.
    Goya L; Alexander DB; Webster MK; Kern FG; Guzman RC; Nandi S; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1816-22. PubMed ID: 8467500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
    Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid growth suppression response in 13762NF adenocarcinoma-derived Con8 rat mammary tumor cells is mediated by dominant trans-acting factors.
    Webster MK; Guthrie J; Firestone GL
    Cancer Res; 1991 Nov; 51(22):6031-8. PubMed ID: 1933866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
    Goya L; Maiyar AC; Ge Y; Firestone GL
    Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-alpha abrogates glucocorticoid-stimulated tight junction formation and growth suppression in rat mammary epithelial tumor cells.
    Buse P; Woo PL; Alexander DB; Cha HH; Reza A; Sirota ND; Firestone GL
    J Biol Chem; 1995 Mar; 270(12):6505-14. PubMed ID: 7896785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of rat mammary tumor cell growth in vitro by glucocorticoids requires serum proteins. Characterization of wild type and glucocorticoid-resistant epithelial tumor cells.
    Webster MK; Guthrie J; Firestone GL
    J Biol Chem; 1990 Mar; 265(9):4831-8. PubMed ID: 2318865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
    Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional glucocorticoid receptor modulates pancreatic carcinoma growth through an autocrine loop.
    Norman J; Franz M; Schiro R; Nicosia S; Docs J; Fabri PJ; Gower WR
    J Surg Res; 1994 Jul; 57(1):33-8. PubMed ID: 7518883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes.
    Meisler N; Shull S; Xie R; Long GL; Absher M; Connolly JP; Cutroneo KR
    J Cell Biochem; 1995 Nov; 59(3):376-88. PubMed ID: 8567755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta production and induction of cellular responses in 13762NF rat mammary adenocarcinoma cell clones.
    Kaufmann AM; Stoeck M; Schirrmacher V; Lichtner RB
    Invasion Metastasis; 1993; 13(5):244-52. PubMed ID: 7960577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of recombinant retroviral vector expressing antisense TGF alpha on malignant phenotype of human pancreatic carcinoma cell line.
    Xu Y; Liu T; Gao J
    Chin Med J (Engl); 1998 Apr; 111(4):334-8. PubMed ID: 10374398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-alpha abrogates the glucocorticoid stimulation of tight junction formation and reverses the steroid-induced down-regulation of fascin in rat mammary epithelial tumor cells by a Ras-dependent pathway.
    Guan Y; Woo PL; Rubenstein NM; Firestone GL
    Exp Cell Res; 2002 Feb; 273(1):1-11. PubMed ID: 11795941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
    Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET
    Cancer Gene Ther; 1997; 4(1):42-50. PubMed ID: 9012450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA; Sergina N; Yang H; Ziober B; Willson JK; Zborowska E; Humphrey LE; Fan R; Ko TC; Brattain MG; Howell GM
    Cancer Res; 2003 Aug; 63(15):4731-8. PubMed ID: 12907656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
    Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.